Viracta Therapeutics Inc (VIRX)
0.84
+0.02
(+2.43%)
USD |
NASDAQ |
May 02, 16:00
0.845
0.00 (0.00%)
After-Hours: 20:00
Viracta Therapeutics Market Cap: 32.99M for May 2, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 02, 2024 | 32.99M |
| May 01, 2024 | 32.21M |
| April 30, 2024 | 32.19M |
| April 29, 2024 | 32.24M |
| April 26, 2024 | 32.53M |
| April 25, 2024 | 33.26M |
| April 24, 2024 | 32.84M |
| April 23, 2024 | 33.30M |
| April 22, 2024 | 34.56M |
| April 19, 2024 | 33.64M |
| April 18, 2024 | 35.70M |
| April 17, 2024 | 36.77M |
| April 16, 2024 | 28.07M |
| April 15, 2024 | 30.63M |
| April 12, 2024 | 45.16M |
| April 11, 2024 | 45.95M |
| April 10, 2024 | 44.77M |
| April 09, 2024 | 41.63M |
| April 08, 2024 | 42.02M |
| April 05, 2024 | 40.06M |
| April 04, 2024 | 40.84M |
| April 03, 2024 | 42.81M |
| April 02, 2024 | 42.81M |
| April 01, 2024 | 43.59M |
| March 28, 2024 | 40.06M |
| Date | Value |
|---|---|
| March 27, 2024 | 42.41M |
| March 26, 2024 | 42.41M |
| March 25, 2024 | 41.63M |
| March 22, 2024 | 38.09M |
| March 21, 2024 | 42.02M |
| March 20, 2024 | 44.38M |
| March 19, 2024 | 39.67M |
| March 18, 2024 | 38.88M |
| March 15, 2024 | 39.12M |
| March 14, 2024 | 38.09M |
| March 13, 2024 | 37.31M |
| March 12, 2024 | 38.68M |
| March 11, 2024 | 34.96M |
| March 08, 2024 | 33.39M |
| March 07, 2024 | 31.81M |
| March 06, 2024 | 36.12M |
| March 05, 2024 | 37.10M |
| March 04, 2024 | 36.92M |
| March 01, 2024 | 35.58M |
| February 29, 2024 | 31.86M |
| February 28, 2024 | 34.79M |
| February 27, 2024 | 29.71M |
| February 26, 2024 | 27.37M |
| February 23, 2024 | 27.37M |
| February 22, 2024 | 27.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
16.96M
Minimum
Dec 19 2023
580.82M
Maximum
Feb 26 2021
143.15M
Average
96.53M
Median
Market Cap Benchmarks
| XOMA Corp | 295.76M |
| Marinus Pharmaceuticals Inc | 79.65M |
| Cartesian Therapeutics Inc | 436.00M |
| Adial Pharmaceuticals Inc | 7.258M |
| NovaBay Pharmaceuticals Inc | 2.709M |
Market Cap Related Metrics
| Price to Book Value | 2.564 |
| Price | 0.84 |
| Earnings Yield | -157.1% |